Radiotherapy Complements Immune Checkpoint Blockade

被引：55
|
作者：
Ngiow, Shin Foong [1 ,2 ]
McArthur, Grant A. [3 ,4 ]
Smyth, Mark J. [1 ,2 ]
机构：
[1] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia
[2] Univ Queensland, Sch Med, Herston, Qld 4006, Australia
[3] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Therapeut Programs, East Melbourne, Vic 3002, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia
来源：
CANCER CELL | 2015年 / 27卷 / 04期
关键词：
CANCER; IMMUNOTHERAPY; IPILIMUMAB; RADIATION; MELANOMA; TUMORS; COMBINATION; THERAPY; PATIENT;
D O I：
10.1016/j.ccell.2015.03.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Adaptive immune resistance ablates effective anti-tumor immune responses. In a recent issue of Nature, Victor and colleagues describe that anti-PD-L1 combats adaptive immune resistance upon localized radiation plus anti-CTLA-4 therapy. The superior activity of radiation and dual immune checkpoint blockade is mediated by non-redundant immune mechanisms in cancer.
引用
收藏
页码：437 / 438
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint blockade: timing is everything
    Sinicrope, Frank A.
    Turk, Mary Jo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (08) : 1 - 3
  • [32] Hallmarks of response to immune checkpoint blockade
    Alexandria P Cogdill
    Miles C Andrews
    Jennifer A Wargo
    [J]. British Journal of Cancer, 2017, 117 : 1 - 7
  • [33] The future of microfluidics in immune checkpoint blockade
    Briones, Jonathan
    Espulgar, Wilfred
    Koyama, Shohei
    Takamatsu, Hyota
    Tamiya, Eiichi
    Saito, Masato
    [J]. CANCER GENE THERAPY, 2021, 28 (09) : 895 - 910
  • [34] Activation of phagocytosis by immune checkpoint blockade
    Li, Chia-Wei
    Lai, Yun-Ju
    Hsu, Jennifer L.
    Hung, Mien-Chie
    [J]. FRONTIERS OF MEDICINE, 2018, 12 (04) : 473 - 480
  • [35] Janus-kinase inhibitors impair the development of antitumor immune responses after radiotherapy and immune checkpoint blockade
    Gissibl, Julia
    Timnik, Vincent R.
    Felchle, Hannah
    Nefzger, Sophie M.
    Walther, Caroline N.
    Combs, Stephanie E.
    Fischer, Julius C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S168 - S168
  • [36] Sarcoidosis, malignancy and immune checkpoint blockade
    Gaughan, Elizabeth M.
    [J]. IMMUNOTHERAPY, 2017, 9 (13) : 1051 - 1053
  • [37] Fighting ageing with immune checkpoint blockade
    Sarah Crunkhorn
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 17 - 17
  • [38] Immune checkpoint blockade in infectious diseases
    Michelle N. Wykes
    Sharon R. Lewin
    [J]. Nature Reviews Immunology, 2018, 18 : 91 - 104
  • [39] Fighting ageing with immune checkpoint blockade
    Crunkhorn, Sarah
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (01) : 17 - 17
  • [40] Hallmarks of response to immune checkpoint blockade
    Cogdill, Alexandria P.
    Andrews, Miles C.
    Wargo, Jennifer A.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 117 (01) : 1 - 7
12345